Tesalys Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 18
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 4

Tesalys General Information

Description

Manufacturer of waste material recycling equipment designed to treat biomedical waste. The company manufactures equipment that is offered to laboratories, hemodialysis centers, hospitals and medical facilities for the treatment of bio-contaminated waste materials, enabling clients to reuse waste materials.

Contact Information

Website
www.tesalys.fr
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Machinery (B2B)
Other Industries
Environmental Services (B2B)
Primary Office
  • 7, rue du Cassé
  • 31240 Toulouse
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tesalys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tesalys‘s full profile, request access.

Request a free trial

Tesalys Patents

Tesalys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3048627-B1 Assembly allowing the extraction of waste out of a shredding and decontamination machine of this waste, and allowing the evacuation of this waste Active 09-Mar-2016 00000000
FR-3048627-A1 Assembly for the extraction of waste out of a machine for milling and decontaminating these waste and permitting the disposal of these waste Granted 09-Mar-2016 00000000 0
FR-3028192-B1 Set of elements allowing the extraction of waste from a sterilization machine for such waste, and allowing the evacuation of this waste Active 07-Nov-2014 0000000000
FR-3028192-A1 Set of elements for the extraction of waste out of a sterilization machine of these waste, and for the evacuation of these waste Granted 07-Nov-2014 0000000000
FR-3017548-A1 Machine for the treatment of infectious waste, in particular medical Granted 14-Feb-2014 B09B3/0075
To view Tesalys’s complete patent history, request access »

Tesalys Executive Team (4)

Name Title Board Seat Contact Info
Miquel Lozano Founding Partner, President & Executive, Sales and Marketing
Jean-Michel Rodriguez Founding Partner, Managing Director and Executive, Operations, Administration and Finances
Emmanuel Hengl Technical Director, Founding Partner & Executive, Research and Development
You’re viewing 3 of 4 executive team members. Get the full list »

Tesalys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tesalys Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tesalys‘s full profile, request access.

Request a free trial